Boston Scientific Corp (BSX)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	2,848,000	2,757,000	2,717,000	2,484,000	2,343,000	2,345,000	2,010,000	1,919,000	1,833,000	1,427,000	1,456,000	1,295,000	1,199,000	1,011,000	419,000	86,000	-138,000	80,000	668,000	1,123,000
Revenue (ttm)	US$ in thousands	16,746,000	15,910,000	15,228,000	14,707,000	14,240,000	13,757,000	13,400,000	13,045,000	12,682,000	12,567,000	12,329,000	12,162,000	11,888,000	11,469,000	11,196,000	10,122,000	9,913,000	10,110,000	10,158,000	10,786,000
Operating profit margin		17.01%	17.33%	17.84%	16.89%	16.45%	17.05%	15.00%	14.71%	14.45%	11.36%	11.81%	10.65%	10.09%	8.82%	3.74%	0.85%	-1.39%	0.79%	6.58%	10.41%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $2,848,000K ÷ $16,746,000K
= 17.01%

The operating profit margin of Boston Scientific Corp has shown fluctuations over the period in question. Starting at 10.41% in March 2020, the margin declined to as low as -1.39% by December 2020, indicating a period of decreasing profitability. However, the company managed to improve its performance, with the margin gradually increasing to 17.01% by December 2024. This upward trend suggests that Boston Scientific Corp was able to enhance its operational efficiency and generate more profit from its core business activities over the analyzed period. The company's ability to consistently improve its operating profit margin reflects positively on its management strategies and operational effectiveness.